Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 8
Open access
826
Views
0
CrossRef citations to date
0
Altmetric
Original Articles
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience
George NesrHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomCorrespondence[email protected]
https://orcid.org/0000-0001-7147-843XView further author information
, https://orcid.org/0000-0001-7147-843XView further author information
Raakhee ShahHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Charalampia KyriakouHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Jonathan SiveHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Rakesh PopatHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Kwee YongHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Brendan WisniowskiHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Ke XuHaematology Department, University College London Hospitals NHS Foundation Trust, London, United Kingdomhttps://orcid.org/0000-0002-2453-4475View further author information
, Ashu WechalekarHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Lydia LeeHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Stuart IngsHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Xenofon PapanikolaouHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Shameem MahmoodHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Annabel McmillanHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Jackie HorderHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Fiona NewrickHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Jotham MarfilHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Louise AinleyHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Samir AsherHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
, Simon CheesmanHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
& Neil RabinHaematology Department, University College London Hospitals NHS Foundation Trust, London, United KingdomView further author information
show all
Pages 1465-1471
|
Received 11 Jan 2023, Accepted 17 May 2023, Published online: 01 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.